Neurulation is one of the many important events in mammalian development. It is the stage of organogenesis in vertebrate embryos during which the neural tube is transformed into the primitive structures that will later develop into the central nervous system. Recent transcriptome analysis during neurulation and early organogenesis in humans and mice has identified the global dynamics of gene expression changes across developmental time. This has revealed a richer understanding of gene regulation and provides hints at the transcriptional regulatory networks that underlie these processes. Similarly, epigenome analysis, which collectively constitutes histone modifications, transcription factor binding, and other structural features associated with gene regulation, has given a renewed appreciation to the subtle mechanisms involving the process of neurulation. More specifically, the histone demethylases KDM4A and KDM6B have recently been shown to be key histone H3K4 and H3K27 modifiers that regulate neural crest specification and neural tube closure. Additionally, miRNAs have recently been shown to influence transcription of genes directly or by altering the levels of epigenetic modifiers and thus regulate gene expression. This mini review briefly summarizes the literature, highlighting the transcriptional and epigenetic regulation of key genes involved in neural crest induction and neural crest specification by transcription factors and miRNAs. Understanding how these mechanisms work individually and in clusters will shed light on pathways in the context of diseases associated with neural crest cell derivatives such as melanoma, cardiovascular defects and neuronal craniofacial defects.

Keywords:
Epigenetics, Chromatin remodeling, Folic acid, Gene regulation, microRNA, Neural crest, Neural stem cell, Neural tube, Neurulation
1.
Slonim AD, Pollack MM (ed): Pediatric Critical Care Medicine. Philadelphia, PA, Lippincott Williams and Wilkins, 2006, p 320.
2.
Gilbert SF: The neural crest; in Gilbert SF: Developmental Biology, ed 6. Sunderland, MA, Sinauer Associates, 2000. http://www.ncbi.nlm.nih.gov/books/NBK10065/.
3.
Copp AJ, Greene ND, Murdoch JN: The genetic basis of mammalian neurulation. Nat Rev Genet 2003;4:784-793.
4.
Shakhova O, Sommer L: Neural Crest-Derived Stem Cells. The Stem Cell Research Community, StemBook, 2010, DOI: 10.3824/stembook.3821.3851.3821.
5.
Bronner ME, LeDouarin NM: Development and evolution of the neural crest: an overview. Dev Biol 2012;366:2-9.
6.
Bronner ME, LaBonne C: Preface: the neural crest - from stem cell formation to migration and differentiation. Dev Biol 2012;366:1.
7.
Ambros VG: MicroRNAs and developmental timing. Curr Opin Genet Dev 2011;21:511-517.
8.
Li Z, Rana TM: Molecular mechanisms of RNA-triggered gene silencing machineries. Acc Chem Res 2012;45:1122-1131.
9.
Eberhart JK, He X, Swartz ME, Yan YL, Song H, Boling TC, Kunerth AK, Walker MB, Kimmel CB, Postlethwait JH: MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis. Nat Genet 2008;40:290-298.
10.
Cordes KR, Srivastava D: Micro-RNA regulation of cardiovascular development. Circ Res 2009;104:724-732.
11.
Subramanyam D, Blelloch R: From microRNAs to targets: pathway discovery in cell fate transitions. Curr Opin Genet Dev 2011;21:498-503.
12.
Pasquinelli AE: MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 2012;13:271-282.
13.
Lawson A, Anderson H, Schoenwolf GC: Cellular mechanisms of neural fold formation and morphogenesis in the chick embryo. Anat Rec 2001;262:153-168.
14.
Weinstein DC, Hemmati-Brivanlou A: Neural induction. Annu Rev Cell Dev Biol 1999;15:411-433.
15.
Milet C, Monsoro-Burq AH: Neural crest induction at the neural plate border in vertebrates. Dev Biol 2012;366:22-33.
16.
Milet C, Monsoro-Burq AH: Embryonic stem cell strategies to explore neural crest development in human embryos. Dev Biol 2012;366:96-99.
17.
Sato T, Sasai N, Sasai Y: Neural crest determination by co-activation of Pax3 and Zic1 genes in Xenopus ectoderm. Development 2005;132:2355-2363.
18.
Betancur P, Bronner-Fraser M, Sauka-Spengler T: Assembling neural crest regulatory circuits into a gene regulatory network. Ann Rev Cell Dev Biol 2010;26:581-603.
19.
Duband JL: Diversity in the molecular and cellular strategies of epithelium-to-mesenchyme transitions: insights from the neural crest. Cell Adh Migr 2010;4:458-482.
20.
Burstyn-Cohen T, Stanleigh J, Sela-Donenfeld D, Kalcheim C: Canonical Wnt activity regulates trunk neural crest delamination linking BMP/noggin signaling with G1/S transition. Development 2004;131:5327-5339.
21.
Liu Y, Helms AW, Johnson JE: Distinct activities of Msx1 and Msx3 in dorsal neural tube development. Development 2004;131:1017-1028.
22.
Cheung M, Chaboissier MC, Mynett A, Hirst E, Schedl A, Briscoe J: The transcriptional control of trunk neural crest induction, survival, and delamination. Dev Cell 2005;8:179-192.
23.
Chalpe AJ, Prasad M, Henke AJ, Paulson AF: Regulation of cadherin expression in the chicken neural crest by the Wnt/β-catenin signaling pathway. Cell Adh Migr 2010;4:431-438.
24.
Liu JP, Jessell TM: A role for rhoB in the delamination of neural crest cells from the dorsal neural tube. Development 1998;125:5055-5067.
25.
Sela-Donenfeld D, Kalcheim C: Regulation of the onset of neural crest migration by coordinated activity of BMP4 and Noggin in the dorsal neural tube. Development 1999;126:4749-4762.
26.
Sela-Donenfeld D, Kalcheim C: Inhibition of noggin expression in the dorsal neural tube by somitogenesis: mechanisms for coordinating the timing of neural crest emigration. Development 2000;127:4845-4854.
27.
Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-890.
28.
Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-142.
29.
Lim J, Thiery JP: Epithelial-mesenchymal transitions: insights from development. Development 2012;139:3471-3486.
30.
Taneyhill LA, Coles EG, Bronner-Fraser M: Snail2 directly represses cadherin6B during epithelial-to-mesenchymal transitions of the neural crest. Development 2007;134:1481-1490.
31.
Hatta K, Takagi S, Fujisawa H, Takeichi M: Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev Biol 1987;120:215-227.
32.
Mayor R, Carmona-Fontaine C: Keeping in touch with contact inhibition of locomotion. Trends Cell Biol 2010;20:319-328.
33.
Theveneau E, Mayor R: Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration. Dev Biol 2012;366:34-54.
34.
Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B: SOX9 is a potent activator of the chondrocyte-specific enhancer of the Proα1 (II) collagen gene. Mol Cell Biol 1997;17:2336-2346.
35.
Kelsh RN: Sorting out Sox10 functions in neural crest development. Bioessays 2006;28:788-798.
36.
Potterf SB, Mollaaghababa R, Hou L, Southard-Smith EM, Hornyak TJ, Arnheiter H, Pavan WJ: Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev Biol 2001;237:245-257.
37.
Huber WE, Price ER, Widlund HR, Du J, Davis IJ, Wegner M, Fisher DE: A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. J Biol Chem 2003;278:45224-45230.
38.
Kim J, Lo L, Dormand E, Anderson DJ: SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 2003;38:17-31.
39.
Lang D, Chen F, Milewski R, Li J, Lu MM, Epstein JA: Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-Ret. J Clin Invest 2000;106:963-971.
40.
Lang D, Epstein JA: Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum Mol Genet 2003;12:937-945.
41.
Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, Wegner M: Terminal differentiation of myelin forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 2002;16:165-170.
42.
Schlierf B, Werner T, Glaser G, Wegner M: Expression of connexin47 in oligodendrocytes is regulated by the Sox10 transcription factor. J Mol Biol 2006;361:11-21.
43.
Sieber-Blum M: Epidermal neural crest stem cells and their use in mouse models of spinal cord injury. Brain Res Bull 2010;83:189-193.
44.
Strobl-Mazzulla PH, Marini M, Buzzi A: Epigenetic landscape and miRNA involvement during neural crest development. Dev Dyn 2012;241:1849-1856.
45.
Ichi S, Costa FF, Bischof JM, Nakazaki H, Shen YW, Boshnjaku V, Sharma S, Mania-Farnell B, McLone DG, Tomita T, Soares MB, Mayanil CS: Folic acid remodels chromatin on Hes1 and Neurog2 promoters during caudal neural tube development. J Biol Chem 2010;285:36922-36932.
46.
Pan A, Chang L, Nguyen A, James AW: A review of hedgehog signaling in cranial bone development. Front Physiol 2013;4:61.
47.
Clouthier DE, Gray J, Artinger KB: Micromanaging palate development. Perspect Speech Sci Orofac Disord 2008;18:62-72.
48.
Martínez-Alvarez C, Blanco MJ, Pérez R, Rabadán MA, Aparicio M, Resel E, Martínez T, Nieto MA: Snail family members and cell survival in physiological and pathological cleft palates. Dev Biol 2004;265:207-218.
49.
Nawshad A, Medici D, Liu CC, Hay ED: TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell Sci 2007;120:1646-1653.
50.
Shin JO, Lee JM, Cho KW, Kwak S, Kwon HJ, Lee MJ, Cho SW, Kim KS, Jung HS: MiR-200b is involved in Tgf-β signaling to regulate mammalian palate development. Histochem Cell Biol 2012;137:67-78.
51.
Shin JO, Nakagawa E, Kim EJ, Cho KW, Lee JM, Cho SW, Jung HS: miR-200b regulates cell migration via Zeb family during mouse palate development. Histochem Cell Biol 2012;137:459-470.
52.
Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601.
53.
Park SM, Gaur AB, Lengyel E, Peter ME: The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008;22:894-907.
54.
Small EM, Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature 2011;469:336-342.
55.
Huang ZP, Chen JF, Regan JN, Maguire CT, Tang RH, Dong XR, Majesky MW, Wang DZ: Loss of microRNAs in neural crest leads to cardiovascular syndromes resembling human congenital heart defects. Arterioscler Thromb Vasc Biol 2010;30:2575-2586.
56.
Kirby ML, Hutson MR: Factors controlling cardiac neural crest cell migration. Cell Adh Migr 2010;4:609-621.
57.
Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R: The microprocessor complex mediates the genesis of microRNAs. Nature 2004;432:235-240.
58.
Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN: The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004;18:3016-3027.
59.
Chapnik E, Sasson V, Blelloch R, Hornstein E: Dgcr8 controls neural crest cells survival in cardiovascular development. Dev Biol 2012;362:50-56.
60.
Bolande RP: The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 1974;5:409-429.
61.
Bolande RP: Neurocristopathy: its growth and development in 20 years. Pediatr Pathol Lab Med 1997;17:1-25.
62.
Kaltschmidt B, Kaltschmidt C, Widera D: Adult craniofacial stem cells: sources and relation to the neural crest. Stem Cell Rev 2012;8:658-671.
63.
Stanchina L, Baral V, Robert F, Pingault V, Lemort N, Pachnis V, Goossens M, Bondurand N: Interactions between Sox10, Edn3 and Ednrb during enteric nervous system and melanocyte development. Dev Biol 2006;295:232-249.
64.
Hu YF, Gourab K, Wells C, Clewes O, Schmit BD, Sieber-Blum M: Epidermal neural crest stem cell (EPI-NCSC)-mediated recovery of sensory function in a mouse model of spinal cord injury. Stem Cell Rev 2010;6:186-198.
65.
Wislet-Gendebien S, Poulet C, Neirinckx V, Hennuy B, Swingland JT, Laudet E, Sommer L, Shakova O, Bours V, Rogister B: In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow. PLoS One 2012;7:e46425.
66.
King-Robson J: Encouraging regeneration in the central nervous system: is there a role for olfactory ensheathing cells? Neurosci Res 2010;69:263-275.
67.
Nivet E, Vignes M, Girard SD, Pierrisnard C, Baril N, Devèze A, Magnan J, Lanté F, Khrestchatisky M, Féron F, Roman FS: Engraftment of human nasal olfactory stem cells restores neuroplasticity in mice with hippocampal lesions. J Clin Invest 2011;121:2808-2820.
68.
Hauser S, Widera D, Qunneis F, Müller J, Zander C, Greiner J, Strauss C, Lüningschrör P, Heimann P, Schwarze H, Ebmeyer J, Sudhoff H, Araúzo-Bravo MJ, Greber B, Zaehres H, Schöler H, Kaltschmidt C, Kaltschmidt B: Isolation of novel multipotent neural crest-derived stem cells from adult human inferior turbinate. Stem Cells Dev 2012;21:742-756.
69.
Sieber-Blum M, Hu Y: Epidermal neural crest stem cells (EPI-NCSC) and pluripotency. Stem Cell Rev 2008;4:256-260.
70.
Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
71.
Lüningschrör P, Stöcker B, Kaltschmidt B, Kaltschmidt C: miR-290 cluster modulates pluripotency by repressing canonical NF-κB signaling. Stem Cells 2012;30:655-664.
72.
Yang CS, Rana TM: Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs. Mol Biosyst 2013;9:10-17.
73.
Mazar J, Khaitan D, DeBlasio D, Zhong C, Govindarajan SS, Kopanathi S, Zhang S, Ray A, Perera RJ: Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma. PLoS One 2011;6:e24922.
74.
Perera RJ, Ray A: Epigenetic regulation of miRNA genes and their role in human melanomas. Epigenomics 2012;4:81-90.
75.
Dynoodt P, Mestdagh P, Van Peer G, Vandesompele J, Goossens K, Peelman LJ, Geusens B, Speeckaert RM, Lambert JL, Van Gele MJ: Identification of miR-145 as a key regulator of the pigmentary process. J Invest Dermatol 2013;133:201-209.
76.
Yang B, Guo H, Zhang Y, Ying D, Dong S: MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS One 2012;6:e21679.
77.
Yamashita S, Miyaki S, Kato Y, Yokoyama S, Sato T, Barrionuevo F, Akiyama H, Scherer G, Takada S, Asahara H: L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity. J Biol Chem 2012;287:22206-22215.
78.
Nakamura Y, He X, Kato H, Wakitani S, Kobayashi T, Watanabe S, Iida A, Tahara H, Warman ML, Watanapokasin R, Postlethwait JH: Sox9 is upstream of microRNA-140 in cartilage. Appl Biochem Biotechnol 2012;166:64-71.
79.
Farrell BC, Power EM, McDermott KW: Developmentally regulated expression of Sox9 and microRNAs 124, 128 and 23 in neuroepithelial stem cells in the developing spinal cord. Int J Dev Neurosci 2011;29:31-36.
80.
Grandjean V, Gounon P, Wagner N, Martin L, Wagner KD, Bernex F, Cuzin F, Rassoulzadegan M: The miR-124-Sox9 paramutation: RNA-mediated epigenetic control of embryonic and adult growth. Development 2009;136:3647-3655.
81.
Dai L, Zhang X, Hu X, Zhou C, Ao Y: Silencing of microRNA-101 prevents IL-1β-induced extracellular matrix degradation in chondrocytes. Arthritis Res Ther 2012;14:R268.
82.
Lee MR, Kim JS, Kim KS: miR-124a is important for migratory cell fate transition during gastrulation of human embryonic stem cells. Stem Cells 2010;28:1550-1559.
83.
Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, Cao DX, Chen GQ, He JR, Zhao Q: MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013;34:713-722.
84.
Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K: MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene 2013;32:296-306.
85.
Siemens H, Jackstadt R, Hünten S, Kaller M, Menssen A, Götz U, Hermeking H: miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 2011;10:4256-4271.
86.
Takwi AA, Li Y, Becker Buscaglia LE, Zhang J, Choudhury S, Park AK, Liu M, Young KH, Park WY, Martin RC, Li Y: A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med 2012;4:896-909.
87.
Huang TH, Wu F, Loeb GB, Hsu R, Heidersbach A, Brincat A, Horiuchi D, Lebbink RJ, Mo YY, Goga A, McManus MT: Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J Biol Chem 2009;284:18515-18524.
88.
Sehic A, Risnes S, Khuu C, Khan QE, Osmundsen H: Effects of in vivo transfection with anti-miR-214 on gene expression in murine molar tooth germ. Physiol Genomics 2011;43:488-498.
89.
Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB: Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 2009;37:123-128.
90.
Sokol NS, Ambros V: Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 2005;19:2343-2354.
91.
Gokey NG, Srinivasan R, Lopez-Anido C, Krueger C, Svaren J: Developmental regulation of microRNA expression in Schwann cells. Mol Cell Biol 2012;32:558-568.
92.
Adijanto J, Castorino JJ, Wang ZX, Maminishkis A, Grunwald GB, Philp NJ: Microphthalmia-associated transcription factor (MITF) promotes differentiation of human retinal pigment epithelium (RPE) by regulating microRNAs-204/211 expression. J Biol Chem 2012;287:20491-20503.
93.
Levy C, Khaled M, Robinson KC, Veguilla RA, Chen PH, Yokoyama S, Makino E, Lu J, Larue L, Beermann F, Chin L, Bosenberg M, Song JS, Fisher DE: Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell 2010;141:994-1005.
94.
Haflidadóttir BS, Bergsteinsdóttir K, Praetorius C, Steingrímsson E: miR-148 regulates Mitf in melanoma cells. PLoS One 2010;5:e11574.
95.
Bemis LT, Chen R, Amato CM, et al: MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 2008;68:1362-1368.
96.
Goswami S, Tarapore RS, Teslaa JJ, Grinblat Y, Setaluri V, Spiegelman VS: MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. J Biol Chem 2010;285:20532-20540.
97.
Zhu Z, He J, Jia X, Jiang J, Bai R, Yu X, Lv L, Fan R, He X, Geng J, You R, Dong Y, Qiao D, Lee KB, Smith GW, Dong C: MicroRNA-25 functions in regulation of pigmentation by targeting the transcription factor MITF in Alpaca (Lama pacos) skin melanocytes. Domest Anim Endocrinol 2010;38:200-209.
98.
Dey BK, Gagan J, Yan Z, Dutta A: miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev 2012;26:2180-2191.
99.
Hu W, Ye Y, Zhang W, Wang J, Chen A, Guo F: miR-142-3p promotes osteoblast differentiation by modulating Wnt signaling. Mol Med Rep 2013;7:689-693.
100.
Sheehy NT, Cordes KR, White MP, Ivey KN, Srivastava D: The neural crest-enriched microRNA miR-452 regulates epithelial-mesenchymal signaling in the first pharyngeal arch. Development 2010;137:4307-4316.
101.
Okamoto H, Matsumi Y, Hoshikawa Y, Takubo K, Ryoke K, Shiota G: Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells. PLoS One 2012;7:e43800.
102.
Motohashi N, Alexander MS, Casar JC, Kunkel LM: Identification of a novel microRNA that regulates the proliferation and differentiation in muscle side population cells. Stem Cells Dev 2012;21:3031-3043.
103.
Goljanek-Whysall K, Sweetman D, Abu-Elmagd M, Chapnik E, Dalmay T, Hornstein E, Münsterberg A: MicroRNA regulation of the paired-box transcription factor Pax3 confers robustness to developmental timing of myogenesis. Proc Natl Acad Sci USA 2011;108:11936-11941.
104.
Mosakhani N, Guled M, Lahti L, Borze I, Forsman M, Pääkkönen V, Ryhänen J, Knuutila S: Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway. Mod Pathol 2010;23:1544-1552.
105.
Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST: Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008;68:5049-5058.
106.
Wong CF, Tellam RL: MicroRNA-26a targets the histone methyltransferase enhancer of zeste homolog 2 during myogenesis. J Biol Chem 2008;283:9836-9843.
107.
Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3a and 3b. Proc Natl Acad Sci USA 2007;104:15805-15810.
108.
Cao P, Deng Z, Wan M, Huang W, Cramer SD, Xu J, Lei M, Sui G: MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer 2010;9:108.
109.
Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH: Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 2007;10:1513-1514.
110.
Lehmann U, Hasemeier B, Christgen M, Müller M, Römermann D, Länger F, Kreipe H: Epigenetic inactivation of microRNA gene HSA-miR-9-1 in human breast cancer. J Pathol 2008;214:17-24.
111.
Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, Dahiya R: miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 2009;28:1714-1724.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.